drugset / Trial / NCT02875015

Liposomal Bupivacaine vs. Bupivacaine Hydrochloride and Lidocaine During Suburethral Sling Placement

NCT02875015 ↗

Completed 57 enrolled Atlantic Health System
RandomizedParallel-groupSingle-blindPrevention

Summary

Postoperative pain, the quality of their recovery and the opioid consumption following a midurethral sling placement are being compared between 2 groups. One group will have the hydro-dissection performed with a diluted liposomal bupivacaine solution. The other group will have the hydro-dissection performed with a diluted bupivacaine HCL and Lidocaine solution.

Timeline

Start
2016-04
Primary completion
2018-05
Completion
2018-05

Drugs

EvaluationDrugModalityDoseRoute
Comparator Bupivacaine Other / unclassified 20 ml Other
Comparator Bupivacaine Other / unclassified 50 ml Other
Comparator Lidocaine Other / unclassified 30 ml Other

Indications

No indication recorded.